Online citations, reference lists, and bibliographies.
← Back to Search

Characterization Of Biophysical And Metabolic Properties Of Cells Labeled With Superparamagnetic Iron Oxide Nanoparticles And Transfection Agent For Cellular MR Imaging.

A. Arbab, Lindsey A Bashaw, B. R. Miller, E. Jordan, B. Lewis, H. Kalish, J. Frank
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
PURPOSE To evaluate the effect of using the ferumoxides-poly-l-lysine (PLL) complex for magnetic cell labeling on the long-term viability, function, metabolism, and iron utilization of mammalian cells. MATERIALS AND METHODS PLL was incubated with ferumoxides for 60 minutes, incompletely coating the superparamagnetic iron oxide (SPIO) through electrostatic interactions. Cells were coincubated overnight with the ferumoxides-PLL complex, and iron uptake, cell viability, apoptosis indexes, and reactive oxygen species formation were evaluated. The disappearance or the life span of the detectable iron nanoparticles in cells was also evaluated. The iron concentrations in the media also were assessed at different time points. Data were expressed as the mean +/- 1 SD, and one-way analysis of variance and the unpaired Student t test were used to test for significant differences. RESULTS Intracytoplasmic nanoparticles were stained with Prussian blue when the ferumoxides-PLL complex had magnetically labeled the human mesenchymal stem and HeLa cells. The long-term viability, growth rate, and apoptotic indexes of the labeled cells were unaffected by the endosomal incorporation of SPIO, as compared with these characteristics of the nonlabeled cells. In nondividing human mesenchymal stem cells, endosomal iron nanoparticles could be detected after 7 weeks; however, in rapidly dividing cells, intracellular iron had disappeared by five to eight divisions. A nonsignificant transient increase in reactive oxygen species production was seen in the human mesenchymal stem and HeLa cell lines. Labeled human mesenchymal stem cells did not differentiate to other lineage. A significant increase in iron concentration was observed in both the human mesenchymal stem and HeLa cell media at day 7. CONCLUSION Magnetic cellular labeling with the ferumoxides-PLL complex had no short- or long-term toxic effects on tumor or stem cells.
This paper references
Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo.
E. Porreca (1994)
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination.
J. Bulte (1999)
In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO
M. Rausch (2002)
Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids.
J. Gutteridge (1982)
In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging.
T. Skotland (2002)
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
Iron deprivation‐induced apoptosis in HL‐60 cells
K. Fukuchi (1994)
Derivation of pluripotent stem cells from cultured human primordial germ cells
M. Shamblott (1998)
Embryonic stem cell lines derived from human blastocysts.
J. Thomson (1998)
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
J. Frank (2003)
Stem cells — hype and hope
R. McKay (2000)
Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat
M. Hoehn (2002)
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage
M. Rausch (2001)
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.
J. Ferrucci (1990)
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.
J. Frank (2002)
Multilineage potential of adult human mesenchymal stem cells.
M. Pittenger (1999)
Mesenchymal stem cells: biology and potential clinical uses.
R. J. Deans (2000)
Iron metabolism, free radicals, and oxidative injury.
J. Emerit (2001)
Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism.
D. Pouliquen (1991)

This paper is referenced by
Neuroimaging as a basis for rational stem cell therapy.
S. Ashwal (2009)
Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.
Yuqing Ge (2009)
Design of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cells.
Jun Ichiro Jo (2010)
Labeling of mesenchymal stromal cells with iron oxide-poly(l-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties
G. Schmidtke-Schrezenmeier (2011)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
A. Khakoo (2006)
In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction
P. Hua (2015)
MRI of tumor angiogenesis
T. Barrett (2007)
Iron-containing Nanoparticles for the Treatment of Chrionic Biofilm Infections in Cystic Fibrosis
L. M. A. Martín (2019)
In Vivo MRI Stem Cell Tracking Requires Balancing of Detection Limit and Cell Viability
K. Nohroudi (2010)
Molecular imaging of mesothelin expressing cancers
Ripen Misri (2010)
Magnetoplex based on MnFe2O4 nanocrystals for magnetic labeling and MR imaging of human mesenchymal stem cells
Jaemoon Yang (2010)
Molecular Imaging of Stem Cells and Exosomes for Myocardial Regeneration
M. Santoso (2017)
Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking
Changqiang Wu (2015)
Ultrastructural characterization of mesenchymal stromal cells labeled with ultrasmall superparamagnetic iron-oxide nanoparticles for clinical tracking studies
L. Hansen (2014)
Molecular and Stem Cell Imaging maging Stem Cells Implanted in Infarcted Myocardium
ong Zhou (2006)
Comparison of Superparamagnetic Iron Oxide Labeling Efficiency between Poly-L-Lysine and Protamine Sulfate for Human Mesenchymal Stem Cells: Quantitative Analysis Using Multi-Echo T2* Magnetic Resonance Imaging
Ji Yeon Suh (2013)
Measurement of quantity of iron in magnetically labeled cells: comparison among different UV/VIS spectrometric methods.
A. M. Rad (2007)
Macrophages loaded with gold nanoshells for photothermal ablation of glioma: An in vitro model
Amani Riad Makkouk (2010)
The Design and Control of Stability and Magnetic Properties of Imaging Nanoparticles
Ki Youl Yoon (2012)
Imaging stem cells implanted in infarcted myocardium.
R. Zhou (2006)
Noninvasive Tracking of Encapsulated Insulin Producing Cells Labelled with Magnetic Microspheres by Magnetic Resonance Imaging
V. Vaithilingam (2016)
Efficient encapsulation of Fe₃O₄ nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications.
L. Shen (2015)
Magnetic Resonance Imaging with Superparamagnetic Iron Oxide Fails to Track the Long-term Fate of Mesenchymal Stem Cells Transplanted into Heart
N. Ma (2015)
Characterization of labeled neural progenitor cells for magnetic targeting
T. Hamasaki (2005)
Biological applications of magnetic nanoparticles.
M. Colombo (2012)
Current Awareness in NMR in biomedicine
Relaxometry model of strong dipolar perturbers for balanced‐SSFP: Application to quantification of SPIO loaded cells
R. Lebel (2006)
A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent
F. Xiong (2017)
Magnetic resonance imaging of chondrocytes labeled with superparamagnetic iron oxide nanoparticles in tissue-engineered cartilage.
S. Ramaswamy (2009)
Suivi par IRM du destin in vivo des cellules souches mésenchymateuses dérivées de la moelle osseuse, marquées par des nanoparticules d’oxyde de fer superparamagnétique et injectées par voie intra-articulaire chez le lapin
X. Jing (2008)
A physiologically based pharmacokinetic model to predict the superparamagnetic iron oxide nanoparticles (SPIONs) accumulation in vivo
Adny Henrique Silva (2017)
Effects of Hydroxyapatite-Iron Oxide Nanocomposite Against Human Glioblastoma Cells
Sebastian Pernal (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar